Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 930270
                    [Title] => FDA reviewing heart risks of Glaxo diabetes pill
                    [Summary] => 
The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster drug Avandia, which was severely restricted in 2010 due to concerns about its impact on the heart.

                    [DatePublished] => 2013-04-13 08:00:08
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 824102
                    [Title] => GlaxoSmithKline to pay $3B for health fraud
                    [Summary] => 
British drugmaker GlaxoSmithKline will pay $3 billion in fines – the largest health care fraud settlement in US history – for criminal and civil violations involving 10 drugs that are taken by millions of people.
                    [DatePublished] => 2012-07-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 2649
                    [Title] => `Mga International Bugaw na Call Center Agents’
                    [Summary] => 
            
                    [DatePublished] => 2007-05-28 00:00:00
                    [ColumnID] => 133619
                    [Focus] => 0
                    [AuthorID] => 1167424
                    [AuthorName] => Ben Tulfo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

Avandia

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 930270
                    [Title] => FDA reviewing heart risks of Glaxo diabetes pill
                    [Summary] => 
The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster drug Avandia, which was severely restricted in 2010 due to concerns about its impact on the heart.

                    [DatePublished] => 2013-04-13 08:00:08
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 824102
                    [Title] => GlaxoSmithKline to pay $3B for health fraud
                    [Summary] => 
British drugmaker GlaxoSmithKline will pay $3 billion in fines – the largest health care fraud settlement in US history – for criminal and civil violations involving 10 drugs that are taken by millions of people.
                    [DatePublished] => 2012-07-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 2649
                    [Title] => `Mga International Bugaw na Call Center Agents’
                    [Summary] => 
            
                    [DatePublished] => 2007-05-28 00:00:00
                    [ColumnID] => 133619
                    [Focus] => 0
                    [AuthorID] => 1167424
                    [AuthorName] => Ben Tulfo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

abtest

FDA reviewing heart risks of Glaxo diabetes pill

April 13, 2013 - 8:00am

The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster drug Avandia, which was severely restricted in 2010 due to concerns about its impact on...

World

GlaxoSmithKline to pay $3B for health fraud

July 4, 2012 - 12:00am

British drugmaker GlaxoSmithKline will pay $3 billion in fines – the largest health care fraud settlement in US history – for criminal and civil violations involving 10 drugs that are taken by millions...

Business

`Mga International Bugaw na Call Center Agents’

By Ben Tulfo | May 28, 2007 - 12:00am

Headlines